Protopanaxatriol Ginsenoside Rh1 Upregulates Phase II Antioxidant Enzyme Gene Expression in Rat Primary Astrocytes: Involvement of MAP Kinases and Nrf2/ARE Signaling |
Jung, Ji-Sun
(Department of Molecular Medicine, Tissue Injury Defense Research Center, Ewha Womans University Medical School)
Lee, Sang-Yoon (Life and Nanopharmaceutical Sciences, College of Pharmacy, Kyung Hee University) Kim, Dong-Hyun (Life and Nanopharmaceutical Sciences, College of Pharmacy, Kyung Hee University) Kim, Hee-Sun (Department of Molecular Medicine, Tissue Injury Defense Research Center, Ewha Womans University Medical School) |
1 | Alam, J. and Cook, J. L. (2007) How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am. J. Respir. Cell Mol. Biol. 36, 166-174. DOI |
2 | Cheng, Y., Shen, L. H. and Zhang, J. T. (2005) Anti-amnestic and antiaging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol. Sin. 26, 143-149. DOI |
3 | Dallerac, G., Chever, O. and Rouach, N. (2013) How do astrocytes shape synaptic transmission? Insights from electrophysiology. Front. Cell. Neurosci. 7, 159. |
4 | Hou, J., Xue, J., Lee, M., Yu, J. and Sung, C. (2014) Long-term administration of Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. Int. J. Mol. Med. 33, 234-240. DOI |
5 | Jaiswal, A. K. (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Rad. Biol. Med. 36, 1199-1207. DOI |
6 | Jung, J. S., Kim, D. H. and Kim, H. S. (2010a) Ginsenoside Rh1 suppresses inducible nitric oxide synthase gene expression in IFNgamma- stimulated microglia via modulation of JAK/STAT and ERK signaling pathways. Biochem. Biophys. Res. Commun. 397, 323- 328. DOI |
7 | Jung, J. S., Shin, J. A., Park, E. M., Lee, J. E., Kang, Y. S., Min, S. W., Kim, D. H., Hyun, J. W., Shin, C. Y. and Kim, H. S. (2010b) Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide- stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J. Neurochem. 115, 1668-1680. DOI |
8 | Jung, J. S., Ahn, J. H., Le, T. K., Kim, D. H. and Kim, H. S. (2013) Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells. Neurochem. Int. 63, 80-86. DOI |
9 | Lee, E. J., Ko, H. M., Jeong, Y. H., Park, E. M. and Kim, H. S. (2015a) Beta-lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia. J. Neuroinflammation 12, 133. DOI |
10 | Lee, J. M. and Johnson, J. A. (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. J. Biochem. Mol. Biol. 37, 139-143. DOI |
11 | Lee, S. Y., Jeong, J. J., Eun, S. H. and Kim, D. H. (2015b) Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induded colitis. Eur. J. Pharmacol. 762, 333-343. DOI |
12 | Park, J. S., Park, E. M., Kim, D. H., Jung, K., Jung, J. S., Lee, E. J., Hyun, J. W., Kang, J. L. and Kim H. S. (2009) Anti-inflammatory mechanism of ginseng saponins in activated microglia. J. Neuroimmunol. 209, 40-49. DOI |
13 | Li, J., Du, J., Liu, D., Cheng, B., Fang, F., Weng, L., Wang, C. and Ling, C. (2014) Ginsenoside Rh1 potentiates dexamethasone's anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance. Arthritis Res. Ther. 16, R106. DOI |
14 | Niture, S. K., Kaspar, J. W., Shen, J. and Jaiswal, A. K. (2010) Nrf2 signaling and cell survival. Toxicol. App. Pharmacol. 244, 37-42. DOI |
15 | Park, E. K., Choo, M. K., Han, M. J. and Kim, D. H. (2004) Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Immunol. 133, 113-120 DOI |
16 | Park, J. S., Jung, J. S., Jeong, Y. H., Hyun, J. W., Le, T. K., Kim, D. H., Choi, E. C. and Kim, H. S. (2011) Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression. J. Neurochem. 119, 909-919. DOI |
17 | Park, J. S. and Kim, H. S. (2014) Regulation of hemeoxygenase-1 gene expression by Nrf2 and c-Jun in tertiary butylhydroquinonestimulated rat primary astrocytes. Biochem. Biophys. Res. Commun. 447, 672-677. DOI |
18 | Qin, L., Block, M. L., Liu, Y., Bienstock, R. J., Pei, Z., Zhang, W., Wu, X., Wilson, B., Burka, T. and Hong, J. S. (2005) Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J. 19, 550-557. DOI |
19 | Sofroniew, M. V. and Vinters, H. V. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35. DOI |
20 | Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C., Lee, B. Y. and Kim, D. H. (2006) The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate- and oxazolone- induced mouse dermatitis models. Planta Med. 72, 376-378. DOI |
21 | Sun, Z., Huang, Z. and Zhang, D. D. (2009) Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 4:e6588. DOI |
22 | Syapin, P. J. (2008) Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 155, 623-640. |
23 | Vargas, M. R. and Johnson, J. A. (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 11, e17. DOI |
24 | Venugopal, R. and Jaiswal, A. K. (1998) Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17, 3145-3156. DOI |
25 | Wang, Y. Z., Chen, J., Chu, S. F., Wang, Y. S., Wang, X. Y., Chen, N. H. and Zhang, J. T. (2009) Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's metabolites ginsenoside Rh1 and protopanaxatriol. J. Pharmacol. Sci. 109, 504-510. DOI |
26 | Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J. and Zhang, F. (2013) Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog. Neurobiol. 100, 30-47. DOI |
27 | Zhu, D., Wu, L. and Li, C. R. (2009) Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J. Cell Biochem. 108, 117-124 DOI |
28 | Zheng, H., Jeong, Y., Song, J. and Ji, G. E. (2011) Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitislike lesions induced by oxazolone in hairless mice. Int. Immunopharmacol. 11, 511-518. DOI |